Skip to content
soligenix-logo Soligenix Logo
Main Menu
  • About Soligenix
    • Corporate Overview
    • Board of Directors
    • Executive Team
    • Scientific Advisory Boards
      • Scientific Advisory Board Cutaneous T-Cell Lymphoma
      • Scientific Advisory Board Oral Mucositis
      • Scientific Advisory Board Pediatric Crohn’s Disease
      • Scientific Advisory Board Antibiotic Resistance & Emerging Infectious Disease
  • Careers
    • Job Openings
  • Contact
  • Pipeline + Programs
    • Pipeline
    • Specialized BioTherapeutics
      • HyBryte™ Cutaneous T-Cell Lymphoma (CTCL) Treatment
      • SGX942 for Oral Mucositis Treatment
      • SGX203 for Pediatric Crohn’s Disease
      • SGX302, Plaque Psoriasis Treatment for Mild to Moderate Psoriasis
    • Public Health Solutions
      • RiVax® to Prevent Ricin Poisoning
      • SGX943 for Bacterial Infection Treatment
      • ThermoVax®: Thermostable Vaccines for Global Use
    • Reference Literature
      • Specialized BioTherapeutics
      • Public Health Solutions
    • Relevant Publications
  • Clinical Trials
  • Our Focus
    • Specialized BioTherapeutics
      • Cutaneous T-Cell Lymphoma
      • Oral Mucositis
      • Pediatric Crohn’s Disease
      • Psoriasis
    • Public Health Solutions
      • What is Ricin Intoxication?
      • Thermal Stabilization of Vaccines
      • Antibiotic Resistant & Emerging Infectious Disease
  • Partnering
  • Investors
T-cell masthead image

ThermoVax®

Poster

Thermostable Subunit Vaccine Results in Protective Immunity in Rhesus Macaques in an Inhalational Ricin Model – Feb 2015

Leffel, E., Roy, C.J., Brey, R.N., Donini, O. Thermostable Subunit Vaccine Results in Protective Immunity in Rhesus Macaques in an Inhalational Ricin Model. Poster Presentation at 2015 ASM Biodefense and Emerging Diseases Research Meeting. February 9-11, 2015.
Read More
Previous 1 2
© Soligenix, 2022. All Rights Reserved.
  • Legal Notices
  • Site Map
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
  • Instagram